-
1
-
-
0036228886
-
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
-
DOI 10.1002/art.10187
-
Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027. (Pubitemid 34303815)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.4
, pp. 1019-1027
-
-
Cervera, R.1
Piette, J.-C.2
Font, J.3
Khamashta, M.A.4
Shoenfeld, Y.5
Camps, M.T.6
Jacobsen, S.7
Lakos, G.8
Tincani, A.9
Kontopoulou-Griva, I.10
Galeazzi, M.11
Meroni, P.L.12
Derksen, R.H.W.M.13
De Groot, P.G.14
Gromnica-Ihle, E.15
Baleva, M.16
Mosca, M.17
Bombardieri, S.18
Houssiau, F.19
Gris, J.-C.20
Quere, I.21
Hachulla, E.22
Vasconcelos, C.23
Roch, B.24
Fernandez-Nebro, A.25
Boffa, M.-C.26
Hughes, G.R.V.27
Ingelmo, M.28
more..
-
2
-
-
0142040432
-
Neuronal and Astrocytic Damage in Systemic Lupus Erythematosus Patients with Central Nervous System Involvement
-
DOI 10.1002/art.11279
-
Trysberg E, Nylen K, Rosengren LE, et al. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003; 48: 2881-2887. (Pubitemid 37280617)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.10
, pp. 2881-2887
-
-
Trysberg, E.1
Nylen, K.2
Rosengren, L.E.3
Tarkowski, A.4
-
3
-
-
0032908439
-
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes
-
Chapman J, Cohen-Armon M, Shoenfeld Y, et al. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8: 127-133. (Pubitemid 29103599)
-
(1999)
Lupus
, vol.8
, Issue.2
, pp. 127-133
-
-
Chapman, J.1
Cohen-Armon, M.2
Shoenfeld, Y.3
Korczyn, A.D.4
-
6
-
-
70449729881
-
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: A case-control study
-
Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
-
(2009)
Lancet Neurol
, vol.8
, pp. 998-1005
-
-
Urbanus, R.T.1
Siegerink, B.2
Roest, M.3
-
7
-
-
0027989330
-
The anticardiolipin antibody in elderly stroke patients: Its effects on stroke types, recurrence, and the coagulation-fibrinolysis system
-
Tohgi H, Takahashi H, Kasiwaya M, Watanabe K, Hayama K. The anticardiolipin antibody in elderly Stroke patients: its effects on stroke types, recurrence and the coagulation-fibrinolysis system. Acta Neurol Scand 1994; 90: 86-90. (Pubitemid 24261202)
-
(1994)
Acta Neurologica Scandinavica
, vol.90
, Issue.2
, pp. 86-90
-
-
Tohgi, H.1
Takahashi, H.2
Kashiwaya, M.3
Watanabe, K.4
Hayama, K.5
-
8
-
-
0029031918
-
Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome
-
Levine SR, Brey RL, Sawaya KL, et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995; 38: 119-124.
-
(1995)
Ann Neurol
, vol.38
, pp. 119-124
-
-
Levine, S.R.1
Brey, R.L.2
Sawaya, K.L.3
-
9
-
-
0343567810
-
Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death
-
APASS
-
APASS. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 1997; 48: 91-94.
-
(1997)
Neurology
, vol.48
, pp. 91-94
-
-
-
10
-
-
0344931870
-
Anticardiolipin antibodies are an independent risk factor for ischemic stroke
-
Zielinska J, Ryglewicz D, Wierzchoska E, Lechowicz W, Hier DB, Czlonkiwska A. Anticardiolipin antibodies are an independent risk factor for ischemic stroke. Neurol Res 1999; 21: 653-657. (Pubitemid 29510835)
-
(1999)
Neurological Research
, vol.21
, Issue.7
, pp. 653-657
-
-
Zielinska, J.1
Ryglewicz, D.2
Wierzchowska, E.3
Lechowicz, W.4
Hier, D.B.5
Czlonkowska, A.6
-
11
-
-
0035009690
-
Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: A prospective study
-
DOI 10.1007/s004150170176
-
Heinzlef O, Abuaf N, Cohen A, Amarenco P French Study of Aortic Plaques in Stroke Group. Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study. J Neurology 2001; 248: 373-379. (Pubitemid 32477327)
-
(2001)
Journal of Neurology
, vol.248
, Issue.5
, pp. 373-379
-
-
Heinzlef, O.1
Abuaf, N.2
Cohen, A.3
Amarenco, P.4
-
12
-
-
0036126596
-
Anticardiolipin antibodies and mortality in patients with ischemic stroke: A prospective follow-up study
-
DOI 10.1159/000048623
-
Tanne D, D'Olhaberriague L, Trivedi AM, Salowich-Palm L, Schyltz LR, Levine SR. Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study. Neuroepidemiology 2002; 21: 93-99. (Pubitemid 34233893)
-
(2002)
Neuroepidemiology
, vol.21
, Issue.2
, pp. 93-99
-
-
Tanne, D.1
D'Olhaberriague, L.2
Trivedi, A.M.3
Salowich-Palm, L.4
Schultz, L.R.5
Levine, S.R.6
-
13
-
-
10744223871
-
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
-
DOI 10.1001/jama.291.5.576
-
Levine SR, Brey RL, Tilley BC, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-584. (Pubitemid 38500311)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.5
, pp. 576-584
-
-
Levine, S.R.1
-
14
-
-
33750122025
-
Anticardiolipin antibodies, recurrent stroke and vascular events: A prospective study on 210 patients
-
Tanasescu R, Ticmeanu M, Nicolau A, et al. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients. Rom J Inter Med 2005; 43: 79-88.
-
(2005)
Rom J Inter Med
, vol.43
, pp. 79-88
-
-
Tanasescu, R.1
Ticmeanu, M.2
Nicolau, A.3
-
15
-
-
58149149373
-
Pediatric antiphospholipid syndrome: Clinical and immunologic features of 121 patients in an international registry
-
Avcin T, Cimaz R, Silverman ED, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics 2008; 122: e1100-e1107.
-
(2008)
Pediatrics
, vol.122
-
-
Avcin, T.1
Cimaz, R.2
Silverman, E.D.3
-
16
-
-
39449121252
-
A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
-
DOI 10.1002/art.23334
-
Avcin T, Benseler SM, Tyrrell PN, et al. A follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 2008; 59: 206-213. (Pubitemid 351272956)
-
(2008)
Arthritis Care and Research
, vol.59
, Issue.2
, pp. 206-213
-
-
Avcin, T.1
Benseler, S.M.2
Tyrrell, P.N.3
Cucnik, S.4
Silverman, E.D.5
-
17
-
-
0027936392
-
High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia
-
Angelini L, Ravelli A, Caporali R, et al. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994; 94: 500-503. (Pubitemid 24295030)
-
(1994)
Pediatrics
, vol.94
, Issue.4 I
, pp. 500-503
-
-
Angelini, L.1
Ravelli, A.2
Caporali, R.3
Rumi, V.4
Nardocci, N.5
Martini, A.6
-
18
-
-
0141891339
-
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients
-
DOI 10.1097/01.md.0000091181.93122.55
-
Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308. (Pubitemid 37229465)
-
(2003)
Medicine
, vol.82
, Issue.5
, pp. 299-308
-
-
Cervera, R.1
Khamashta, M.A.2
Font, J.3
Sebastiani, G.D.4
Gil, A.5
Lavilla, P.6
Mejia, J.C.7
Aydintug, A.O.8
Chwalinska-Sadowska, H.9
De Ramon, E.10
Fernandez-Nebro, A.11
Galeazzi, M.12
Valen, M.13
Mathieu, A.14
Houssiau, F.15
Caro, N.16
Alba, P.17
Ramos-Casals, M.18
Ingelmo, M.19
Hughes, G.R.V.20
more..
-
19
-
-
33846621547
-
Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus
-
DOI 10.1161/01.STR.0000254476.05620.14, PII 0000767020070200000028
-
Mikdashi J, Handwerger B, Langenberg P, Miller M, Kittner S. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 2007; 38: 281-285. (Pubitemid 46184295)
-
(2007)
Stroke
, vol.38
, Issue.2
, pp. 281-285
-
-
Mikdashi, J.1
Handwerger, B.2
Langenberg, P.3
Miller, M.4
Kittner, S.5
-
20
-
-
10444248119
-
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events
-
Toloza SM, Uribe AG, McGwin Jr G, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004; 50: 3947-3957.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3947-3957
-
-
Toloza, S.M.1
Uribe, A.G.2
McGwin Jr., G.3
-
21
-
-
25644443865
-
Risk factors for recurrent thrombosis: Prospective study of a cohort of Japanese systemic lupus erythematosus
-
DOI 10.1177/000331970505600512
-
Akimoto T, Kobayashi S, Tamura N, et al. Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus. Angiology 2005; 56: 601-609. (Pubitemid 41383314)
-
(2005)
Angiology
, vol.56
, Issue.5
, pp. 601-609
-
-
Akimoto, T.1
Kobayashi, S.2
Tamura, N.3
Ohsawa, T.4
Kawano, T.5
Tanaka, M.6
Hashimoto, H.7
-
22
-
-
0032908586
-
A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus
-
DOI 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O
-
Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728-734. (Pubitemid 29171993)
-
(1999)
Arthritis and Rheumatism
, vol.42
, Issue.4
, pp. 728-734
-
-
Hanly, J.G.1
Hong, C.2
Smith, S.3
Fisk, J.D.4
-
23
-
-
0032913451
-
A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus
-
DOI 10.1002/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L
-
Menon S, Jameson-Shortall E, Newman Hall-Craggs SP, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 735-741. (Pubitemid 29171994)
-
(1999)
Arthritis and Rheumatism
, vol.42
, Issue.4
, pp. 735-741
-
-
Menon, S.1
Jameson-Shortall, E.2
Newman, S.P.3
Hall-Craggs, M.R.4
Chinn, R.5
Isenberg, D.A.6
-
24
-
-
12544253380
-
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus
-
McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.
-
(2005)
Neurology
, vol.64
, pp. 297-303
-
-
McLaurin, E.Y.1
Holliday, S.L.2
Williams, P.3
Brey, R.L.4
-
25
-
-
37349066221
-
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus
-
Tomietto P, Annese V, D'agostini S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007; 57: 1461-1472.
-
(2007)
Arthritis Rheum
, vol.57
, pp. 1461-1472
-
-
Tomietto, P.1
Annese, V.2
D'Agostini, S.3
-
26
-
-
45049088504
-
Primary antiphospholipid syndrome in Latin American mestizo patients: Clinical and immunologic characteristics and comparison with European patients
-
Mejia-Romero R, Garcia-Carrasco M, Galarza-Maldonado C, et al. Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients. Clin Rheumatol 2008; 27: 891-897.
-
(2008)
Clin Rheumatol
, vol.27
, pp. 891-897
-
-
Mejia-Romero, R.1
Garcia-Carrasco, M.2
Galarza-Maldonado, C.3
-
27
-
-
0036242218
-
Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics
-
DOI 10.1136/jnnp.72.5.647
-
Heinzlef O, Weill B, Johanet C, et al. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry 2002; 72: 647-649. (Pubitemid 34462823)
-
(2002)
Journal of Neurology Neurosurgery and Psychiatry
, vol.72
, Issue.5
, pp. 647-649
-
-
Heinzlef, O.1
Weill, B.2
Johanet, C.3
Sazdovitch, V.4
Caillat-Zucman, S.5
Tournier-Lasserve, E.6
Roullet, E.7
-
28
-
-
0035092781
-
Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis
-
DOI 10.1002/ana.81
-
Sastre-Garriga J, Reverter JC, Font J, et al. Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol 2001; 49: 408-411. (Pubitemid 32202798)
-
(2001)
Annals of Neurology
, vol.49
, Issue.3
, pp. 408-411
-
-
Sastre-Garriga, J.1
Reverter, J.C.2
Font, J.3
Tintore, M.4
Espinosa, G.5
Montalban, X.6
-
29
-
-
0033850322
-
Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: A study of 89 patients
-
Roussel V, Yi F, Jauberteau MO, et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun 2000; 14: 259-265.
-
(2000)
J Autoimmun
, vol.14
, pp. 259-265
-
-
Roussel, V.1
Yi, F.2
Jauberteau, M.O.3
-
30
-
-
38849123295
-
Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: A preliminary study
-
Bidot CJ, Horstman LL, Jimenez JJ, et al. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol 2007; 7: 36.
-
(2007)
BMC Neurol
, vol.7
, pp. 36
-
-
Bidot, C.J.1
Horstman, L.L.2
Jimenez, J.J.3
-
31
-
-
0033984834
-
Can neurologic manifestations of hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature
-
DOI 10.1097/00005792-200001000-00006
-
Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000; 79: 57-68. (Pubitemid 30077737)
-
(2000)
Medicine
, vol.79
, Issue.1
, pp. 57-68
-
-
Cuadrado, M.J.1
Khamashta, M.A.2
Ballesteros, A.3
Godfrey, T.4
Simon, M.J.5
Hughes, G.R.V.6
-
32
-
-
0032940259
-
Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS?
-
Ijdo JW, Conti-Kelly AM, Greco P, et al. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS? Lupus 1999; 8: 109-115.
-
(1999)
Lupus
, vol.8
, pp. 109-115
-
-
Ijdo, J.W.1
Conti-Kelly, A.M.2
Greco, P.3
-
33
-
-
0031754511
-
A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?
-
Karussis D, Leker RR, Ashkenazi A, et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998; 44: 629-634.
-
(1998)
Ann Neurol
, vol.44
, pp. 629-634
-
-
Karussis, D.1
Leker, R.R.2
Ashkenazi, A.3
-
35
-
-
0028354654
-
Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
-
Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 586-571.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 586-1571
-
-
Herranz, M.T.1
Rivier, G.2
Khamashta, M.A.3
Blaser, K.U.4
Hughes, G.R.V.5
-
36
-
-
0029815233
-
Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients
-
Liou HH, Wang CR, Chen CJ, et al. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996; 5: 307-312.
-
(1996)
Lupus
, vol.5
, pp. 307-312
-
-
Liou, H.H.1
Wang, C.R.2
Chen, C.J.3
-
37
-
-
0035019921
-
2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: Association with the presence of seizures
-
DOI 10.1191/096120301671577528
-
Shrivastava A, Dwivedi S, Aggarwal A, Misra R. Anti-cardiolipin and anti-beta2 glycoprotein 1 antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus 2001; 10: 45-50. (Pubitemid 32416688)
-
(2001)
Lupus
, vol.10
, Issue.1
, pp. 45-50
-
-
Shrivastava, A.1
Dwivedi, S.2
Aggarwal, A.3
Misra, R.4
-
38
-
-
8844244629
-
Epileptic seizures in systemic lupus erythematosus
-
Appenzeller S, Cendes F, Costallat LTL. Epileptic seizures in systemic lupus erythematosus. Neurology 2004; 63: 1808-1812. (Pubitemid 39532373)
-
(2004)
Neurology
, vol.63
, Issue.10
, pp. 1808-1812
-
-
Appenzeller, S.1
Cendes, F.2
Costallat, L.T.L.3
-
39
-
-
0029003563
-
Significance of antibodies to cardiolipin in selected patients with systemic lupus erythematosus: Clinical and laboratory associations
-
The SLE Study Group
-
Sachse C, Luthke K, Hartung K, et al. Significance of antibodies to cardiolipin in selected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group. Rheumatol Int 1995; 15: 23-29.
-
(1995)
Rheumatol Int
, vol.15
, pp. 23-29
-
-
Sachse, C.1
Luthke, K.2
Hartung, K.3
-
40
-
-
0030624994
-
Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients
-
Formiga F, Mitjavila F, Pac M, Moga I. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients. Lupus 1997; 6: 486.
-
(1997)
Lupus
, vol.6
, pp. 486
-
-
Formiga, F.1
Mitjavila, F.2
Pac, M.3
Moga, I.4
-
41
-
-
0030797383
-
Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy
-
DOI 10.1016/S0002-9343(97)90046-2, PII S0002934397000466
-
Verrot D, San-Marco M, Dravet C, et al. Prevalence and significance of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 1997; 103: 33-37. (Pubitemid 27314185)
-
(1997)
American Journal of Medicine
, vol.103
, Issue.1
, pp. 33-37
-
-
Verrot, D.1
San-Marco, M.2
Dravet, C.3
Genton, P.4
Disdier, P.5
Bolla, G.6
Harle, J.-R.7
Reynaud, L.8
Weiller, P.-J.9
-
42
-
-
79953307645
-
Antiphospholipid and antinuclear antibodies in patients with epilepsy or new onset seizure disorders
-
Peltola JT, Haapala A, Isojarvi JI, et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new onset seizure disorders. Am J Med 2000; 103: 33-37.
-
(2000)
Am J Med
, vol.103
, pp. 33-37
-
-
Peltola, J.T.1
Haapala, A.2
Isojarvi, J.I.3
-
43
-
-
0003304517
-
Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies
-
Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in SLE: Prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992. (Pubitemid 36529618)
-
(2003)
Journal of Rheumatology
, vol.30
, Issue.5
, pp. 985-992
-
-
Sanna, G.1
Bertolaccini, M.L.2
Cuadrado, M.J.3
Laing, H.4
Khamashta, M.A.5
Mathieu, A.6
Hughes, G.R.V.7
|